$60.92 -0.54 (%) Bristol-Myers Squibb Co - NYSE

Feb. 27, 2015 | 04:00 PM

Partner Headlines

  1. Bristol Myers Reports Data Supporting Clinical Development Of BMS-955176

    Benzinga | Feb. 26, 2015 | 08:35AM EST
  2. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  3. Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug

    Benzinga | Feb. 25, 2015 | 12:57PM EST
  4. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  5. Bristol-Myers goes for the gut

    IBD | Feb. 23, 2015 | 18:33PM EST
  6. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  7. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  8. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  9. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST
  10. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga | Feb. 23, 2015 | 07:34AM EST
  11. Jefferies Names AbbVie As Top Pharmaceutical Pick, Offers Alternative Choices

    Benzinga | Feb. 20, 2015 | 13:10PM EST
  12. Strong Dollar Weakens Views

    IBD | Jan. 27, 2015 | 18:48PM EST
  13. Drugmakers Warn On Dollar

    IBD | Jan. 27, 2015 | 18:47PM EST
  14. Strong Dollar Pins U.S. Corporate Earnings Outlook

    IBD | Jan. 27, 2015 | 18:29PM EST
  15. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  16. Strong Dollar Means Flabby Outlook For Some Overseas

    IBD | Jan. 27, 2015 | 13:45PM EST
  17. Bristol, Pfizer, Novartis Forecasts Face FX Pressures

    IBD | Jan. 27, 2015 | 11:57AM EST
  18. Tuesday Morning Movers: Microsoft, Procter & Gamble Tumble Following Earnings

    Benzinga | Jan. 27, 2015 | 09:19AM EST
  19. UPDATE: Bristol-Meyers Squibb Posts Upbeat Q4 Results, Issues Downbeat Forecast

    Benzinga | Jan. 27, 2015 | 08:39AM EST
  20. Earnings Scheduled For January 27, 2015

    Benzinga | Jan. 27, 2015 | 04:34AM EST
  21. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  22. 3 High-Flying Health Care Stock IPOs To Watch In 2015

    IBD | Jan. 21, 2015 | 17:09PM EST
  23. BRISTOL-MYERS SQUIBB

    IBD | Jan. 20, 2015 | 18:44PM EST
  24. Bristol-Myers Squibb Names Caforio CEO, Andreotti To Become Chairman

    Benzinga | Jan. 20, 2015 | 17:09PM EST
  25. Feeling Good With This Med Company

    GuruFocus | Jan. 20, 2015 | 15:12PM EST
  26. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  27. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  28. Celgene Outlook Is Upbeat

    IBD | Jan. 12, 2015 | 18:58PM EST
  29. Celgene, Bristol-Myers Cancer Drug News Lifts Stocks

    IBD | Jan. 12, 2015 | 18:48PM EST
  30. Bristol-Myers Hits 14-Year High On Cancer Drug Trial

    IBD | Jan. 12, 2015 | 14:25PM EST
  31. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  32. Morning Market Gainers

    Benzinga | Jan. 12, 2015 | 09:42AM EST
  33. Credit Suisse: Keep An Eye On These 6 Healthcare Stocks In 2015

    Benzinga | Jan. 11, 2015 | 12:59PM EST
  34. What Investors Should Expect From Portola Pharmaceutical's Upcoming Data Readouts

    Benzinga | Jan. 9, 2015 | 12:43PM EST
  35. Jim Cramer Advises His Viewers On Wynn Resorts And Second Sight Medical Products

    Benzinga | Jan. 6, 2015 | 07:53AM EST
  36. Bristol-Myers Squibb and California Institute for Biomedical Research Sign Worldwide Research Collaboration and License Agreement Focused on New Treatment Approaches for Fibrotic Diseases

    Benzinga | Jan. 5, 2015 | 08:01AM EST
  37. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
  38. FDA's OKs may prescribe hits

    IBD | Dec. 26, 2014 | 18:49PM EST
  39. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  40. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD | Dec. 13, 2014 | 08:02AM EST
  41. Celgene drug could gain share

    IBD | Dec. 11, 2014 | 19:00PM EST
  42. Celgene's Abraxane Succeeds In Early Breast Cancer

    IBD | Dec. 11, 2014 | 11:27AM EST
  43. Merck's Keytruda Might Treat Virulent Breast Cancer

    IBD | Dec. 10, 2014 | 11:04AM EST
  44. US Stock Futures Edge Lower Ahead Of Federal Budget

    Benzinga | Dec. 10, 2014 | 07:01AM EST
  45. T Rowe Price's Top Stakes for the Third Quarter

    GuruFocus | Dec. 9, 2014 | 10:16AM EST
  46. I think Zimmer Will Outperform S&P 500 Performance

    GuruFocus | Dec. 4, 2014 | 10:06AM EST
  47. Avanir Stock Jumps On $3.5 Billion Otsuka Buyout

    IBD | Dec. 2, 2014 | 11:22AM EST
  48. A Buy Recommendation From Absolute Valuation Model to Bristol-Myers Squibb

    GuruFocus | Nov. 24, 2014 | 13:05PM EST
  49. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  50. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
Trading Center